Valneva Se Stock Fundamentals
| VLA Stock | EUR 2.02 0.07 3.35% |
Valneva SE fundamentals help investors to digest information that contributes to Valneva SE's financial success or failures. It also enables traders to predict the movement of Valneva Stock. The fundamental analysis module provides a way to measure Valneva SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valneva SE stock.
Valneva |
Valneva SE Company Return On Equity Analysis
Valneva SE's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Valneva SE Return On Equity | -1.86 |
Most of Valneva SE's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Valneva SE has a Return On Equity of -1.8614. This is much lower than that of the sector and significantly lower than that of the Return On Equity industry. The return on equity for all Austria stocks is notably higher than that of the company.
Valneva SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE is rated fifth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Valneva SE by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Valneva SE's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Valneva Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valneva SE's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics of similar companies.Valneva SE is currently under evaluation in return on equity category among its peers.
Valneva Fundamentals
| Return On Equity | -1.86 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.53 B | |||
| Shares Outstanding | 76.5 M | |||
| Shares Owned By Insiders | 17.56 % | |||
| Shares Owned By Institutions | 21.62 % | |||
| Price To Earning | 239.23 X | |||
| Price To Sales | 1.31 X | |||
| Revenue | 438.74 M | |||
| Gross Profit | (13.12 M) | |||
| EBITDA | 37.72 M | |||
| Net Income | (73.42 M) | |||
| Cash And Equivalents | 69.94 M | |||
| Cash Per Share | 1.11 X | |||
| Total Debt | 73.72 M | |||
| Debt To Equity | 55.90 % | |||
| Current Ratio | 3.06 X | |||
| Book Value Per Share | 1.56 X | |||
| Cash Flow From Operations | 76.9 M | |||
| Earnings Per Share | (0.71) X | |||
| Number Of Employees | 762 | |||
| Beta | 0.99 | |||
| Market Capitalization | 554.21 M | |||
| Z Score | 4.2 |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Valneva SE, a biotech company, engages in developing and commercializing vaccines for infectious diseases with unmet needs. It has operations in Austria, Sweden, the United Kingdom, France, Canada, and the United States. VALNEVA SE is traded on Vienna Stock Exchange in Austria.
Currently Active Assets on Macroaxis
Other Information on Investing in Valneva Stock
Valneva SE financial ratios help investors to determine whether Valneva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.